Patricia Lohr, Medical Director and Responsible Officer at BPAS, said:
“This study contributes yet more compelling evidence that telemedicine is a safe, effective, and patient-centred way of providing early medical abortion. Telemedical abortion care has protected women’s health and wellbeing during the pandemic, and women have told us how much they value the service and want it to continue so other women in the future can benefit. While other healthcare services have been suspended or seen significant increases in waiting times during the pandemic, access to abortion has not only been maintained but has improved, enabling women to end pregnancies at the earliest possible gestations.
“At a time when the NHS is under severe strain, the ability to provide a better service that women prefer at a lower cost is rare. It would make no sense for the government to remove a service model that has clear benefits to the health and wellbeing of patients. The government are now in a position to secure a world-leading reproductive healthcare framework, and we urge the Secretary of State to do so by making telemedical abortion care a permanent option.”
For further information please contact BPAS on email@example.com or 07881 265276.
BPAS is a charity which sees almost 100,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception at clinics across Great Britain. It supports and advocates for reproductive choice. BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here: https://www.bpas.org/get-involved/centre-for-reproductive-research-communication/
BPAS will be launching a not-for-profit fertility service in 2021 to provide ethical, evidence-based, person-centred care that supports patients. We intend to only charge what it costs to provide a safe, high-quality, and accessible service to patients who may be unable to access NHS-funded care.